301230 泓博醫藥
按盤價 
42.640 -0.990 (-2.269%)
42.640 -0.990 (-2.269%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.338 | 3.367 | 1.589 | 3.373 | 9.194 |
| 總資產報酬率 ROA (%) | 1.808 | 2.607 | 1.219 | 2.698 | 7.227 |
| 投入資產回報率 ROIC (%) | 1.994 | 2.842 | 1.329 | 2.925 | 7.847 | 邊際利潤分析 |
| 銷售毛利率 (%) | 31.921 | 27.416 | 23.864 | 30.875 | 36.874 |
| 營業利潤率 (%) | 15.323 | 4.158 | 0.667 | 7.646 | 15.211 |
| 息稅前利潤/營業總收入 (%) | 17.256 | 5.003 | 0.830 | 7.388 | 13.687 |
| 淨利潤/營業總收入 (%) | 13.802 | 4.982 | 3.138 | 7.682 | 14.028 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 48.451 | 114.517 | -261.844 | 107.784 | 95.280 |
| 價值變動淨收益/利潤總額(%) | 70.381 | 25.079 | 237.822 | 16.890 | 0.691 |
| 營業外收支淨額/利潤總額(%) | -1.593 | -1.074 | -2.769 | -1.854 | 0.105 | 償債能力分析 |
| 流動比率 (X) | 3.760 | 3.380 | 4.420 | 3.824 | 9.284 |
| 速動比率 (X) | 3.169 | 2.950 | 3.870 | 3.503 | 8.778 |
| 資產負債率 (%) | 21.727 | 23.580 | 21.553 | 24.854 | 14.476 |
| 帶息債務/全部投入資本 (%) | 3.268 | 3.546 | 3.139 | 3.369 | 2.505 |
| 股東權益/帶息債務 (%) | 2,623.758 | 2,392.297 | 2,675.380 | 2,473.390 | 3,608.381 |
| 股東權益/負債合計 (%) | 360.259 | 324.082 | 363.973 | 302.350 | 590.777 |
| 利息保障倍數 (X) | 7.939 | 5.627 | 4.595 | -61.885 | -8.885 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 73.446 | 64.239 | 60.889 | 61.593 | 64.138 |
| 存貨周轉天數 (天) | 63.272 | 51.550 | 56.649 | 59.822 | 58.265 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 08/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
